| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/12/1998 | WO1998005330A1 Treatment of psychotic disorders |
| 02/12/1998 | WO1998005329A1 Il-8 receptor antagonists |
| 02/12/1998 | WO1998005328A1 Il-8 receptor antagonists |
| 02/12/1998 | WO1998005326A1 Method for treating nicotine withdrawal |
| 02/12/1998 | WO1998005325A1 Method for treating disruptive behavior disorders |
| 02/12/1998 | WO1998005324A1 Method for treating bipolar disorder |
| 02/12/1998 | WO1998005323A2 Method of regulating the female reproductive system through angiogenesis inhibitors |
| 02/12/1998 | WO1998005322A1 Verapamil as a medicament for the treatment of angina |
| 02/12/1998 | WO1998005321A1 Therapeutic utilities of verapamil enantiomers |
| 02/12/1998 | WO1998005320A1 Coated trimebutine maleate tablet |
| 02/12/1998 | WO1998005319A1 Methods of preventing skeletal problems in poultry |
| 02/12/1998 | WO1998005318A1 Conjugated linoleic acid to maintain or enhance bone mineral content |
| 02/12/1998 | WO1998005317A1 Il-8 receptor antagonists |
| 02/12/1998 | WO1998005316A1 Drugs for improving ocular circulation disorders |
| 02/12/1998 | WO1998005315A1 Pentafluorobenzenesulfonamides and analogs |
| 02/12/1998 | WO1998005314A1 Novel stable liquid paracetamol compositions, and method for preparing same |
| 02/12/1998 | WO1998005313A1 Composition comprising mupirocin and chlorhexidine |
| 02/12/1998 | WO1998005312A1 Pleasant-tasting aqueous liquid composition of a bitter-tasting drug |
| 02/12/1998 | WO1998005311A1 Use of bronopol for the treatment of diseases in fish |
| 02/12/1998 | WO1998005308A2 Terazosin capsules |
| 02/12/1998 | WO1998005306A1 Controlled release tablet formulation of isosorbide-5-mononitrate |
| 02/12/1998 | WO1998005303A1 Bioadhesive complexes of polycarbophil and azole antifungal or antiprotozoal drugs |
| 02/12/1998 | WO1998005293A2 Method of regulating the female reproductive system through angiogenesis inhibitors |
| 02/12/1998 | WO1998005292A2 Piperidine and piperazine derivatives and their use as muscarinic antagonists |
| 02/12/1998 | WO1998005291A2 Method for treating mental retardation |
| 02/12/1998 | WO1998005211A1 Improved method for systemic administration of 2,4-dienoic acid-type insecticides to terrestrial mammals |
| 02/12/1998 | WO1998005208A1 Method for treating substance abuse |
| 02/12/1998 | WO1998005207A1 Method for treating excessive aggression |
| 02/12/1998 | WO1998001740A3 Diagnosis of williams syndrome and williams syndrome cognitive profile by analysis of a lim-kinase gene |
| 02/12/1998 | WO1998001100A3 Method for treating homozygous familial hypercholesterolemia |
| 02/12/1998 | WO1998000130A3 Anticonvulsant sulfamate derivatives useful in treating obesity |
| 02/12/1998 | WO1998000129A3 Anticonvulsant derivatives useful in treating psoriasis |
| 02/12/1998 | WO1997047271A3 Cellular vaccines and immunotherapeutics and methods for their preparation |
| 02/12/1998 | WO1997045139A3 Il-12 as an adjuvant for bordetella pertussis vaccines |
| 02/12/1998 | WO1997044354A3 Synthesis of soluble beta-sheet forming peptides |
| 02/12/1998 | WO1997034599A3 Use of clotrimazole and related compounds in the treatment of diarrhea |
| 02/12/1998 | DE19652183C1 Treating oestrogen-dependent tumour with Cimicifuga racemosa extract |
| 02/12/1998 | DE19642872C1 Use of sterol sulphate compounds to inhibit serine protease |
| 02/12/1998 | DE19632042A1 Use of non-peptide bradykinin antagonist compounds |
| 02/12/1998 | CA2791778A1 Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease |
| 02/12/1998 | CA2263154A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 02/12/1998 | CA2262987A1 Anti-ocular circulatory disturbance composition |
| 02/12/1998 | CA2262900A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 02/12/1998 | CA2262648A1 Total synthesis of antitumor acylfulvenes |
| 02/12/1998 | CA2262624A1 A novel method of detecting and treating cancer |
| 02/12/1998 | CA2262614A1 Method for treating disruptive behavior disorders |
| 02/12/1998 | CA2262612A1 Method for treating mental retardation |
| 02/12/1998 | CA2262578A1 Fat emulsion containing xanthine derivative |
| 02/12/1998 | CA2262535A1 Method of regulating the female reproductive system through angiogenesis inhibitors |
| 02/12/1998 | CA2262460A1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use |
| 02/12/1998 | CA2262459A1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 02/12/1998 | CA2262430A1 Composition comprising mupirocin and chlorhexidine |
| 02/12/1998 | CA2262415A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 02/12/1998 | CA2262399A1 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | CA2262223A1 Novel carbocyclic diarylmethylene derivatives, methods for preparing same, and therapeutical uses thereof |
| 02/12/1998 | CA2261946A1 Method for treating nicotine withdrawal |
| 02/12/1998 | CA2261942A1 Method for treating substance abuse |
| 02/12/1998 | CA2261783A1 1,2-diarylindole as cox-2 inhibitors |
| 02/12/1998 | CA2261742A1 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus |
| 02/12/1998 | CA2261676A1 Method for treating excessive aggression |
| 02/12/1998 | CA2261565A1 Hypothalamus-specific polypeptides |
| 02/12/1998 | CA2260786A1 Verapamil as a medicament for the treatment of angina |
| 02/12/1998 | CA2233987A1 Materials and methods for treatment of plaquing diseases |
| 02/12/1998 | CA2233570A1 Detection, prevention and treatment of papillomatous digital dermatitis |
| 02/11/1998 | EP0823767A1 Charging system for electric vehicle |
| 02/11/1998 | EP0823766A1 Cooling charge cable for electric vehicle |
| 02/11/1998 | EP0823478A2 Human cartilage gp 39-like gene |
| 02/11/1998 | EP0823437A2 8-Substituted B-nor-6-thiaequilenin compounds having activity as selective estrogen receptor modulators |
| 02/11/1998 | EP0823436A2 Polymorphic forms I and II of finasteride |
| 02/11/1998 | EP0823428A2 Neuraminic acid derivatives, their preparation and their medical use |
| 02/11/1998 | EP0823426A1 Xanthene and acridine derivatives and their use |
| 02/11/1998 | EP0823413A2 Benzoheterocyclic compounds |
| 02/11/1998 | EP0823254A1 Novel use of pyrazolopyridine compounds |
| 02/11/1998 | EP0822984A1 Human tumor necrosis factor receptors |
| 02/11/1998 | EP0822983A1 Apopain |
| 02/11/1998 | EP0822936A1 NOVEL SUBSTITUTED TETRAHYDROPYRANO 3,2-d]OXAZOLONES, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| 02/11/1998 | EP0822932A1 Piperidine derivatives as diuretic |
| 02/11/1998 | EP0822833A1 Polysaccharide-bound nitric oxide-nucleophile adducts |
| 02/11/1998 | EP0822832A1 Cd45rb binding compounds for the prevention of transplant rejection |
| 02/11/1998 | EP0822823A1 Anionic oxygen radicals containing therapeutic agents and their use in pain relief |
| 02/11/1998 | EP0822822A1 Controlled release of miotic and mydriatic drugs in the anterior chamber |
| 02/11/1998 | EP0822821A1 Complexing urushiols |
| 02/11/1998 | EP0822820A1 NOVEL USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) |
| 02/11/1998 | EP0822819A1 Solvent detergent emulsions having antiviral activity |
| 02/11/1998 | EP0822818A2 Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 02/11/1998 | EP0822817A1 Use of (r)-penciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases |
| 02/11/1998 | EP0822816A1 Dermatological preparation and method for treating actinic keratoses |
| 02/11/1998 | EP0822815A1 A method of making pharmaceutically active taxanes orally bioavailable |
| 02/11/1998 | EP0822814A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 02/11/1998 | EP0822813A1 A combination of a 5-ht uptake inhibitor with a selective 5-ht 1a? antagonist |
| 02/11/1998 | EP0822812A1 Topical treatment and/or prevention of sagging subcutaneous muscle and overlying cutaneous tissue using acetylcholine precursors and catecholamines |
| 02/11/1998 | EP0822811A1 Inhibition of apoptosis in cells expressing fas-ligand following activation |
| 02/11/1998 | EP0822809A1 Controlled release formulation for water soluble drugs in which a passageway is formed in situ |
| 02/11/1998 | EP0822808A2 Composite with sodium starch glycolate as a support material and products thereof |
| 02/11/1998 | EP0822758A1 Supplement for baby infant formula and a method of delivering that supplement |
| 02/11/1998 | EP0822757A1 Stress regulator for animals |
| 02/11/1998 | EP0776323B1 Salts of an anti-migraine indole derivative |
| 02/11/1998 | EP0630263B1 Pharmaceutical composition having site-specific delivery |
| 02/11/1998 | EP0538248B1 Tetrahydroisoquinolinylcarbamates of 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo [2,3-b]indole |
| 02/11/1998 | CN1173206A Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus |